Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
132 hedge funds and large institutions have $212M invested in Epizyme, Inc in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 20 closing their positions.
496% more call options, than puts
Call options by funds: $6.45M | Put options by funds: $1.08M
85% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 20
14% more funds holding
Funds holding: 116 → 132 (+16)
8% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 36
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
56% less capital invested
Capital invested by funds: $480M → $212M (-$268M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$11.4M |
| 2 |
Goldman Sachs
New York
|
+$10.6M |
| 3 |
Millennium Management
New York
|
+$6.02M |
| 4 |
Two Sigma Investments
New York
|
+$3.97M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$3.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$27.5M |
| 2 |
State Street
Boston,
Massachusetts
|
-$16.5M |
| 3 |
Morgan Stanley
New York
|
-$7.54M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.36M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$5.39M |
EPZM Hedge Fund Activity: Q4 2021 in Review
132 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2021, worth a combined $212M — down 56% from $480M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new EPZM positions and 20 closed out — a net gain of 17 holders — while 39 added to existing stakes and 36 trimmed.
The largest buyer was Bank of America, adding an estimated $11.4M. The largest seller was Redmile Group, cutting an estimated $27.5M.
- 132 institutional investors held Epizyme, Inc (EPZM) as of Q4 2021, up from 116 in Q3 2021.
- Funds reported $212M of Epizyme, Inc stock for Q4 2021, down 56% quarter-over-quarter.
- 37 funds opened new Epizyme, Inc positions in Q4 2021 and 20 closed out, a net change of +17 holders.
- The largest Epizyme, Inc buyer in Q4 2021 was Bank of America, an estimated $11.4M added.
- The largest Epizyme, Inc seller in Q4 2021 was Redmile Group, an estimated $27.5M sold.
Based on aggregated 13F filings for Q4 2021.